Share This Page
Suppliers and packagers for FIORICET W/ CODEINE
✉ Email this page to a colleague
FIORICET W/ CODEINE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Ut Inc | FIORICET W/ CODEINE | acetaminophen; butalbital; caffeine; codeine phosphate | CAPSULE;ORAL | 020232 | NDA AUTHORIZED GENERIC | Actavis Pharma, Inc. | 0591-3220-01 | 100 CAPSULE in 1 BOTTLE (0591-3220-01) | 2003-09-18 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: FIORICET W/ CODEINE
Introduction
Fioricet with Codeine is a combination medication used primarily for the relief of moderate to severe migraine headaches. It combines acetaminophen, butalbital, caffeine, and codeine phosphate, a controlled substance. Due to its opioid component, procurement involves strict regulatory oversight, making supplier vetting critical for pharmaceutical entities, distributors, and healthcare institutions. This article offers a comprehensive overview of suppliers involved in manufacturing, distributing, and supplying Fioricet with Codeine, alongside considerations for compliance, sourcing strategies, and market dynamics.
Understanding Fioricet w/ Codeine: Composition and Regulatory Framework
Composition and Use
Fioricet with Codeine combines:
- Acetaminophen: an analgesic and antipyretic.
- Butalbital: a barbiturate with sedative properties.
- Caffeine: a stimulant enhancing analgesic effects.
- Codeine phosphate: an opiate analgesic classified as Schedule III under the Controlled Substances Act (CSA).
This combination provides robust migraine relief but also raises concerns regarding abuse potential and regulatory scrutiny.
Regulatory Landscape
In jurisdictions like the U.S., Fioricet with Codeine is classified as a Schedule III controlled substance, requiring strict manufacturing, distribution, and dispensing oversight (per the DEA). Suppliers must adhere to Good Manufacturing Practices (GMP), possess appropriate licensing, and operate under serial tracking and comprehensive record-keeping systems to prevent diversion.
Major Manufacturers of Fioricet with Codeine
The primary manufacturers producing Fioricet with Codeine are pharmaceutical giants with extensive compliance infrastructure, including:
1. Teva Pharmaceutical Industries
- Overview: One of the world's largest generic drug manufacturers.
- Market Role: Produces licensed formulations of Fioricet with Codeine for the U.S. and global markets.
- Regulatory Compliance: Holds FDA approvals and DEA registrations for controlled substances manufacturing.
- Supply Chain: Regularly supplies pharmacies, hospitals, and distributors with verified batch documentation.
2. Sun Pharmaceutical Industries
- Overview: A leading Indian generic manufacturer with a growing presence in the U.S.
- Manufacturing Capabilities: Produces controlled substance formulations following strict GMP standards.
- Distribution: Supplies to authorized distributors, adhering to U.S. and international regulations.
3. Mylan (now part of Viatris)
- Market Footprint: Offers a wide portfolio of generic controlled substances, including Fioricet with Codeine.
- Regulatory Certification: Maintains comprehensive DEA registration and GMP compliance.
4. Other Regional and Contract Manufacturers
- Several regional players and contract manufacturing organizations (CMOs) produce Fioricet with Codeine under licensing agreements with brand holders or as part of OEM arrangements.
Key Global and Regional Distributors
Beyond manufacturing, a network of specialized pharmaceutical distributors handles the transportation, warehousing, and distribution of Fioricet with Codeine, particularly given its controlled status.
Major Distributors
- AmerisourceBergen: One of the leading pharmaceutical distributors in the U.S., with robust controls for controlled substances.
- McKesson Corporation: Provides extensive distribution channels, maintaining strict compliance.
- Cardinal Health: Offers specialized services for controlled medicines, ensuring regulatory adherence.
- Regional Distributors: In Europe, Asia, and Latin America, licensed regional distributors operate under local regulations, often sourcing from the above global players.
Supply Chain Considerations
Suppliers must ensure a tamper-evident chain of custody, proper storage conditions, and adherence to Serialization and track-and-trace programs (e.g., Drug Supply Chain Security Act [DSCSA] compliance in the U.S.).
Procurement Factors and Challenges
Regulatory Compliance and Licensing
Suppliers must carry valid DEA registrations, adhere to GMP standards, and be compliant with local/national regulations concerning controlled substances.
Verification of Authenticity
Counterfeit drugs pose significant risks; hence, procurement should prioritize suppliers with proper certifications, validated supply chains, and traceability protocols.
Pricing and Market Dynamics
Demand fluctuations, regulatory restrictions, and manufacturing costs impact pricing strategies. Suppliers in regions with strict control measures often face higher compliance costs, reflected in the product's market price.
Accreditation and Quality Assurance
Prospective buyers should verify suppliers' accreditation status, audit histories, and product quality certifications to mitigate risks of substandard or diverted products.
Market Outlook and Strategic Sourcing
The market for Fioricet with Codeine remains – despite regulatory pressures – essential in specific therapeutic niches. However, increasing scrutiny around opioid use has led to tighter controls and a potential shift towards alternative therapies.
Emerging Trends
- Supply Chain Digitization: Adoption of blockchain and serialization enhances transparency.
- Regulatory Harmonization: International efforts aim for unified standards, simplifying global procurement.
- Alternative Formulations: Development of non-opioid migraine treatments may influence future demand.
Strategic Sourcing Recommendations
- Prioritize suppliers with proven regulatory compliance and proven track records.
- Diversify sourcing to mitigate regional risks and supply disruptions.
- Engage in contractual agreements that stipulate quality, timely delivery, and compliance assurances.
- Regularly audit and monitor suppliers to ensure ongoing adherence to GMP and controlled substance regulations.
Conclusion
Securing a reliable, compliant supply of Fioricet with Codeine hinges on partnering with reputable manufacturers and distributors with established regulatory credentials. Given the drug’s classification, procurement processes must rigorously verify licensing, adherence to GMP, and traceability systems. Strategic engagement with trustworthy suppliers facilitates supply chain stability, safeguards against counterfeit products, and ensures regulatory compliance, ultimately supporting optimal patient care.
Key Takeaways
- Only suppliers with valid DEA registration and GMP compliance should be considered for Fioricet with Codeine.
- Leading manufacturers include Teva, Sun Pharma, and Mylan, alongside regional and contract manufacturers.
- Distributors like AmerisourceBergen and McKesson oversee controlled substance logistics, emphasizing traceability and security.
- Supply chain integrity depends on strict adherence to serialization, tracking, and record-keeping protocols.
- Regulatory landscape evolution influences sourcing strategies, necessitating continuous monitoring of compliance standards.
FAQs
1. What regulations govern the supply of Fioricet with Codeine in the U.S.?
Fioricet with Codeine is classified as a Schedule III controlled substance under the DEA. Suppliers must have valid DEA registration, follow GMP standards, and implement proper serialization, record-keeping, and security protocols to prevent diversion and ensure legal compliance [1].
2. How can buyers verify the legitimacy of a Fioricet with Codeine supplier?
Buyers should verify the supplier’s DEA registration, GMP certification, licensing with relevant health authorities, and inspection records. Cross-checking certifications with regulatory agencies and requesting validated documentation enhances supply chain integrity.
3. Are there alternatives to Fioricet with Codeine for migraine treatment?
Yes. Non-opioid options like triptans (e.g., sumatriptan), NSAIDs, and newer migraine-specific therapies (e.g., CGRP antagonists) are available. Regulatory trends favor reducing opioid use, prompting a shift toward these alternatives.
4. What are the risks of procuring Fioricet with Codeine from unverified suppliers?
Risks include product substandard or counterfeit formulations, regulatory penalties, supply disruptions, and legal liabilities stemming from diversion or non-compliance.
5. How does global regulation impact the sourcing of Fioricet with Codeine?
Different countries have varying controlled substance regulations. Understanding regional legal frameworks, licensing requirements, and import-export restrictions is essential for compliant, secure procurement across borders.
References
[1] U.S. Drug Enforcement Administration. (2022). Controlled Substances Act. Available at: https://www.deadiversion.usdoj.gov/21cfr/cfr/21cfr drug code.html
More… ↓
